Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions.
The PSYK ETF (NYSE: PSYK) tracks the Enhanced Consciousness Index.
Dalriada Drug Discovery ("Dalriada") is pleased to announce a strategic collaboration with atai Life Sciences' N.V. (NASDAQ:ATAI) newly launched platform company Invyxis, focused on developing